To read the original article in full go to : Most children labelled allergic to antibiotics may not have an allergy, researchers warn.
Below is a short summary and detailed review of this article written by FutureFactual:
De-labelling penicillin allergy labels in children: GP-guided removal to improve antibiotic use and combat resistance
Author: The Conversation
On a Saturday night in urgent care, a boy with severe tonsillitis illustrates a common problem: an antibiotic allergy label that can misguide treatment for years. The piece explains how many childhood allergy labels begin during viral infections, how they persist, and the risks of unnecessary broad-spectrum antibiotics that follow them. It then outlines GP-led de-labelling strategies to safely remove incorrect allergies, backed by guidance and a 2024 outpatient study showing high success in label removal. Parents are encouraged to discuss review with their child’s GP when they are well, to obtain written confirmation if the label is removed, and to share the change with other caregivers.
- Most penicillin allergy labels are not true allergies
- De-labelling can be safely done in outpatient or primary care settings
- GPs can classify children into three groups for management
- Writing and sharing the outcome improves future care
Author: The Conversation
Overview
The article examines how antibiotic allergy labels in children form, why they persist, and how they can be safely removed. It begins with a vignette: a 10-year-old with tonsillitis in an urgent care centre, whose mother notes a penicillin allergy and a prohibition on any antibiotic ending in -mycin. The first-line antibiotics for tonsillitis typically include penicillin and clarithromycin, so such labels create a difficult clinical scenario, especially when a child is unwell and parents are anxious. The piece emphasizes that these labels often originate from viral infections that cause rashes or other symptoms coinciding with antibiotic use, leading to misattribution of allergy to the drug rather than to the illness or other factors.
Why allergy labels stick
The core problem is that many childhood antibiotic allergy labels begin during viral infections. Rashes, vomiting, fever and headaches can be misinterpreted as allergic reactions, and viruses can be mistaken for drug-induced allergies. Once a label is in a child’s medical record, it can be very hard to remove; the label may persist into adulthood even if the child never had a true allergy. This has tangible consequences for treatment choices, often pushing clinicians toward broader-spectrum antibiotics that are less effective and disrupt a wider range of bacteria. Such practices can contribute to the emergence of antimicrobial resistance and complications like MRSA or C difficile, with longer hospital stays and higher costs.
De-labelling as a solution
The article discusses de-labelling, the process of removing an incorrect allergy label from medical records. It notes that UK guidance already provides a framework for removing inaccurate penicillin labels in hospitals, and suggests that a structured approach can be safely used in outpatient clinics and primary care. A 2024 outpatient study found that 91% of the children assessed had their allergy labels removed after a structured process, indicating that many labels are incorrect and remediable in non-hospital settings.
How GPs can remove labels
GPs can place children into three groups based on symptoms and history, guiding safe management decisions:
- Group 1 includes children whose original symptoms were not typical of an allergy, those who have since tolerated the same antibiotic without problems, or those labelled because a family member had an allergy. For these children, the label can be removed without further tests or specialist referral, and parents can be reassured they can take the medicine.
- Group 2 includes children who developed a mild rash but did not experience severe symptoms such as breathing difficulties or syncope. After careful assessment, a doctor can prescribe a single home dose of the antibiotic, with follow-up after a week. If there is no reaction, the allergy label can be removed. This approach must be overseen by a professional such as a GP or practice pharmacist, and parents should not administer antibiotics without medical advice in the future.
- Group 3 encompasses children with severe reactions, including anaphylaxis or serious mucosal involvement. These children should be referred to paediatric allergy or immunology services. The aim is to avoid exposing truly allergic children to the medicine that caused the reaction.
Practical implications and cautions
Removing uncertain labels can reduce unnecessary use of broader-spectrum antibiotics, contributing to antibiotic stewardship and helping preserve drug effectiveness. Parents are advised to discuss review with their GP ideally when the child is well, obtain written confirmation if the label is removed, and ensure the change is communicated to other healthcare professionals to prevent long-standing mislabeling from dictating future treatments.
Evidence and guidance
The piece notes that UK guidelines already support removing inaccurate penicillin allergy labels in hospitals, and research shows that structured approaches can work in outpatient and primary care settings. The takeaway is that de-labelling, when performed professionally, can be a safe and effective way to improve antibiotic selection for children and contribute to tackling antibiotic resistance.
What families can do
If a child has been told they are allergic to an antibiotic, families should ask their GP whether the diagnosis could be reviewed, ideally when the child is well. If the label is removed, families should receive a clear explanation and written confirmation, and the information should be shared with other relevant healthcare professionals to reduce the likelihood of outdated assumptions guiding future treatment.
In sum, the article advocates for a careful, evidence-based approach to de-labelling penicillin allergy in children, emphasizing the safety and effectiveness of a structured GP-led process and its potential to improve antibiotic stewardship and health outcomes.
